Medical Developments International Limited (ASX:MVP)
0.4350
+0.0050 (1.16%)
Mar 4, 2026, 2:16 PM AEST
ASX:MVP Market Cap
ASX:MVP has a market cap or net worth of 49.01 million as of March 4, 2026. Its market cap has decreased by -43.14% in one year.
Market Cap
49.01M
Enterprise Value
33.96M
Revenue
40.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.44
Market Cap Chart
Since December 19, 2003, ASX:MVP's market cap has increased from 29.06M to 49.01M, an increase of 68.64%. That is a compound annual growth rate of 2.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 48.44M | -22.52% |
| Dec 31, 2025 | 62.53M | 37.04% |
| Dec 31, 2024 | 45.63M | -30.44% |
| Dec 29, 2023 | 65.59M | -48.65% |
| Dec 30, 2022 | 127.73M | -64.16% |
| Dec 31, 2021 | 356.40M | -23.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vita Life Sciences | 144.02M |
| Syntara | 50.66M |
| Little Green Pharma | 33.64M |
| Vitura Health | 30.49M |
| IDT Australia | 21.37M |
| Peak Processing | 19.70M |
| Cann Group | 11.12M |
| Epsilon Healthcare | 9.73M |